JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O'Byrne, S.
Right arrow Articles by Benjamin, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O'Byrne, S.
Right arrow Articles by Benjamin, N.

Vol. 292, Issue 1, 326-330, January 2000

Inhibition of Platelet Aggregation with Glyceryl Trinitrate and Xanthine Oxidoreductase

Sharon O'Byrne, Cheerag Shirodaria , Timothy Millar, Cliff Stevens, David Blake and Nigel Benjamin

Clinical Pharmacology, St. Bartholomew's and the Royal London School of Medicine and Dentistry, London (S.O., C.S., N.B.); and Bone and Joint Research Group, Department of Postgraduate Medicine, University of Bath, Bath (T.M., C.S., D.B.), United Kingdom

Xanthine oxidoreductase (XOR) is a mammalian enzyme that possesses a series of redox centers, which use either NAD+ or molecular oxygen for oxidation of the purines xanthine and hypoxanthine to uric acid. The ability of XOR to act as an NADH oxidase is a less well recognized function of the enzyme, and it is this function that we used to explore the metabolism of glyceryl trinitrate. The antiplatelet effect of nitric oxide (NO) on platelet aggregation was used as a bioassay to assess the bioconversion of glyceryl trinitrate to NO by XOR. The thromboxane mimetic U46619, 2 µM, was used to stimulate platelet aggregation in platelet-rich plasma prepared from healthy drug-free human volunteers. All incubations were carried out at 37°C for 2 min after the addition of U46619. XOR produced a dose-dependent antiaggregant effect when incubated with glyceryl trinitrate (GTN), 220 µM. This did not occur when GTN or XOR was incubated with platelet-rich plasma independently. The antiaggregant effect of XOR plus GTN was dose dependently inhibited by allopurinol, with an IC50 of 100 µM. The addition of superoxide dismutase (SOD), 100 U/ml produced a shift to the left in the antiaggregant dose-response curve for XOR. The IC50 for XOR at 200 U/l without SOD was decreased to 80 U/l with SOD. Oxyhemoglobin, an extracellular NO scavenger, produced a dose-dependent, noncompetitive inhibition of the antiaggregant effect of XOR plus GTN. These findings suggest that GTN may be reduced to NO in vitro by the enzyme XOR in sufficient amounts to inhibit platelet aggregation.


0022-3565/0/2921-0326$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Circ. Res.Home page
J. V. Esplugues, M. Rocha, C. Nunez, I. Bosca, S. Ibiza, J. R. Herance, A. Ortega, J. M. Serrador, P. D'Ocon, and V. M. Victor
Complex I Dysfunction and Tolerance to Nitroglycerin: An Approach Based on Mitochondrial-Targeted Antioxidants
Circ. Res., November 10, 2006; 99(10): 1067 - 1075.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. Oechslin, W. Kiowski, R. Schindler, A. Bernheim, B. Julius, and H. P. Brunner-La Rocca
Systemic Endothelial Dysfunction in Adults With Cyanotic Congenital Heart Disease
Circulation, August 23, 2005; 112(8): 1106 - 1112.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Daiber, M. Oelze, M. Coldewey, M. Bachschmid, P. Wenzel, K. Sydow, M. Wendt, A. L. Kleschyov, D. Stalleicken, V. Ullrich, et al.
Oxidative Stress and Mitochondrial Aldehyde Dehydrogenase Activity: A Comparison of Pentaerythritol Tetranitrate with Other Organic Nitrates
Mol. Pharmacol., December 1, 2004; 66(6): 1372 - 1382.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
U. Hink, M. Oelze, P. Kolb, M. Bachschmid, M.-H. Zou, A. Daiber, H. Mollnau, M. August, S. Baldus, N. Tsilimingas, et al.
Role for peroxynitrite in the inhibition of prostacyclin synthase in nitrate tolerance
J. Am. Coll. Cardiol., November 19, 2003; 42(10): 1826 - 1834.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.